Drugs / surfactant
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT00233324 | Feb 2005 → Feb 2009 | bronchopulmonary dysplasia, fetal growth restriction, retinopathy of prematurity | NICHD Neonatal Research Network | Completed | Missed primary |
| Phase 41 trial | ||||||
| Phase 4 | NCT05714865 | Jun 2023 → Mar 2025 | respiratory distress syndrome in premature infants | Indiana University | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01265589 Comparator | Jan → Dec 2012 | — | Third Military Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Surfactant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05714865 ↗ |
| Action | Restore | “Implement surfactant (BLES®) replacement therapy” NCT05714865 ↗ |
| Route | Other | “into the trachea” NCT05714865 ↗ |